QuidelOrtho Corp (QDEL)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $736.90M
Last updated: Nov 17, 2026 at 11:06 AM ET
QuidelOrtho Corp (QDEL) Stock Forecast
Analysts expect QuidelOrtho (QDEL) to earn $0.67 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.52B. Of 3 analysts, 1 rates the stock Buy or Strong Buy, 1 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 3.33, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 33% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 33.3% |
| Hold | 1 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 33.3% |
- Consensus
- Hold
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 97.0% and revenue estimates are unchanged.
- Fiscal year ending Dec 31, 2026
- $0.67
- EPS consensus, revenue $2.52B
- Fiscal year ending Dec 31, 2027
- $1.32
- EPS consensus, revenue $2.52B
- Next report
- Feb 9, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.67 | $0.66 to $0.67 | 2 | $2.52B | $2.51B to $2.53B | 3 |
| Dec 31, 2027 | $1.32 | $1.31 to $1.32 | 2 | $2.52B | $2.47B to $2.55B | 3 |
Quarterly Estimates
The EPS consensus falls from $0.26 for the quarter ending Dec 31, 2026 to -$0.06 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.26 | $0.25 to $0.27 | 5 | $662.93M | $627.69M to $690.16M | 5 |
| Mar 31, 2027 | -$0.06 | -$0.06 to -$0.05 | 2 | $600.60M | $592.50M to $608.70M | 2 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 14.1% from $0.78.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.67 | $0.77 | $0.77 | $0.77 | $0.78 | -14.5% |
| Fiscal year ending Dec 31, 2027 | $1.32 | $1.43 | $1.44 | $1.44 | $1.47 | -10.5% |
| Quarter ending Mar 31, 2027 | -$0.06 | N/A | $0.01 | $0.01 | $0.02 | N/A |
Frequently Asked Questions About QDEL
What is the QDEL stock forecast?
Consensus analyst estimates put QuidelOrtho's EPS at $0.67 for the fiscal year ending Dec 31, 2026, on revenue of $2.52B. The consensus rating from 3 analysts is Hold.
How do analysts rate QDEL stock?
Of 3 analysts covering QuidelOrtho, 0 rate it Strong Buy, 1 Buy, 1 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from QDEL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.67, with estimates from $0.66 to $0.67 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.32, with estimates from $1.31 to $1.32 from 2 analysts.
What revenue do analysts expect from QuidelOrtho next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.52B, with estimates from $2.51B to $2.53B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.52B, with estimates from $2.47B to $2.55B.
How many analysts cover QDEL?
3 analysts rate QuidelOrtho stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
QDEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts